Abstract: A system includes an optical fiber assembly, a receiver and a telescope, the receiver being positioned at a receiving end of the optical fiber assembly, the telescope being positioned at a collecting end, the receiver being arranged to receive uplink modulated light signals collected by the telescope and travelling through the optical fiber assembly, the telescope comprising an optical concentrator having an inlet face and an outlet face with a surface area smaller than that of the inlet face, the telescope further including a gradient-index lens dispose d coaxially with respect to the optical concentrator so that an inlet face of the gradient-index lens extends opposite the outlet face of the optical concentrator, the collecting end of the optical fiber assembly opening out opposite an outlet face of the gradient-index lens.

Abstract: There is provided mechanisms for handling secondary RAT data usage for a UE. A method is performed by a mobility node. The method comprises obtaining, from a network node, an indication of data usage for the UE using the secondary RAT. The method comprises forwarding the indication towards a policy node. The method comprises obtaining a policy decision originating from the policy node. The policy decision is based on the indication of data usage. The method comprises performing an action based on the policy decision.

Abstract: A lighting and communication system includes a first optical fiber portion, a second optical fiber portion, a third optical fiber portion, a fourth optical fiber portion and a fifth optical fiber portion that are distinct, wherein a visible light transmitter is positioned at a first end of the first optical fiber portion, a modulated light signal transmitter is positioned at a first end of the second optical fiber portion, a second end of the first optical fiber portion and a second end of the second optical fiber portion are connected to a first end of the third optical fiber portion, a modulated light signal receiver is positioned at a first end of the fourth optical fiber portion, a second end of the third optical fiber portion and a second end of the fourth optical fiber portion are connected to a first end of the fifth optical fiber portion.

Abstract: In certain aspects, a method is provided for measuring power using a resistive element coupled between a power amplifier and an antenna. The method includes squaring a voltage from a first terminal of the resistive element to obtain a first signal, squaring a voltage from a second terminal of the resistive element to obtain a second signal, and generating a measurement signal based on a difference between the first signal and the second signal. In some implementations, the resistive element is implemented with a power switch.

Abstract: There is provided mechanisms for handling dual connectivity for a UE. A method is performed by a mobility node. The method comprises: obtaining, from a network node, an indication that the UE supports dual connectivity to a first radio access network and a second radio access network. The method comprises forwarding the indication towards a policy node. The method comprises obtaining information originating from the policy node. The information specifies whether the policy node has determined to allow or restrict access to the second radio access network for the UE. The method comprises forwarding the information towards the network node.

Abstract: The present invention relates to compounds of formula I: in which p, q, Y1, Y2, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a, R5b, R7 and R8 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: Methods, systems and apparatuses may provide for technology that determines the size of a graphics primitive, renders pixels associated with the graphics primitive on a per tile basis if the size exceeds a threshold, and renders the pixels associated with the graphics primitive in a mesh order if the size does not exceed the threshold. In one example, the technology discards state data associated with the graphics primitive in response to a completion of rendering the pixels associated with the graphics primitive in the mesh order.

Abstract: This invention relates to an ex vivo use of the instantaneous frequency modulation (iFM) signal of cardiac activations and to an ex vivo use of the instantaneous amplitude modulation (iAM) signal obtained from the sequence of amplitude excursions of said activations for detecting ‘driver’ or ‘high-hierarchy’ regions and/or the cardiac spots that display the footprint of rotational activations in the heart of a subject with cardiac fibrillation without requiring panoramic simultaneous acquisition.

Abstract: The invention relates to a plenoptic ocular device intended to be coupled in an ocular port of an optical instrument configured to generate a real image of a sample on a focal plane situated in a region close to said ocular port, said plenoptic ocular device being configured to capture said real image, generate a set of elemental images and send them to recording means with spatial discretisation which in turn comprises communication means configured to transmit the set of elemental images to external image processing means.

Abstract: The present invention relates to compounds of formula I: in which Y1, Y2, Y3, Y4 R1, R2, R4a, R4b, R5a, R5b, R6a and R6b are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: Systems and methods for data protection are disclosed. In one embodiment, in an information processing apparatus comprising at least one computer processor, a method for providing data protection may include: (1) receiving a plurality of data classification rules; (2) receiving end user data classification from end user software; (3) receiving developer data classification from SDLC software; (4) generating a data inventory; and (5) applying at least one data protection to the data inventory based on the data classification rules, the end user data classification, and the developer data classification.

Abstract: The present invention relates to compounds of formula I: in which Y1, Y2, R1, R2 and R3 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: A method of preparing a polycarbonate composition, including: melt polymerizing in a polymerization unit a dihydroxy compound with a diaryl carbonate and removing a stream of color inducing species containing an isopropenyl phenyl-containing group from the polymerization unit, to form a polycarbonate composition, wherein the polycarbonate has a color inducing species containing an isopropenyl phenyl-containing group level below 170 ppm is provided.

Abstract: This disclosure provides methods and compositions for genetically manipulating genes and cells.

Abstract: Methods, systems and apparatuses may provide for technology that determines the size of a graphics primitive, renders pixels associated with the graphics primitive on a per tile basis if the size exceeds a threshold, and renders the pixels associated with the graphics primitive in a mesh order if the size does not exceed the threshold. In one example, the technology discards state data associated with the graphics primitive in response to a completion of rendering the pixels associated with the graphics primitive in the mesh order.

Abstract: Systems and methods for dynamic application level encryption are disclosed. In one embodiment, in an information processing apparatus comprising at least one computer processor, a method for dynamic application level encryption include: (1) receiving a plurality of data classification rules; (2) classifying data using the data classification rules; (3) identifying at least one protection option of a plurality of protection options for protecting the data in at least a rest state, an in-transit state, and an in-memory state; and (4) applying the at least one protection option to the data at rest.

Abstract: The present invention relates to compounds of formula I: in which Y1, Y2, Y3, Y4 R1, R2, R4a, R4b, R5a, R5b, R6a and R6b are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: The present invention relates to compounds of formula I: in which p, q, Y1, Y2, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a, R5b, R7 and R8 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: The present invention relates to compounds of formula I: in which Y1, Y2, R1, R2 and R3 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: Methods, systems and apparatuses may provide for technology that determines the size of a graphics primitive, renders pixels associated with the graphics primitive on a per tile basis if the size exceeds a threshold, and renders the pixels associated with the graphics primitive in a mesh order if the size does not exceed the threshold. In one example, the technology discards state data associated with the graphics primitive in response to a completion of rendering the pixels associated with the graphics primitive in the mesh order.